BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zheng SG, Xu HX, Lu MD, Xie XY, Xu ZF, Liu GJ, Liu LN. Role of contrast-enhanced ultrasound in follow-up assessment after ablation for hepatocellular carcinoma. World J Gastroenterol 2013; 19(6): 855-865 [PMID: 23430451 DOI: 10.3748/wjg.v19.i6.855]
URL: https://www.wjgnet.com/1948-5182/full/v19/i6/855.htm
Number Citing Articles
1
Evaluation of tumor response to intra-arterial chemoembolization of hepatocellular carcinoma: Comparison of contrast-enhanced ultrasound with multiphase computed tomographyDiagnostic and Interventional Imaging 2017; 98(3): 253 doi: 10.1016/j.diii.2016.09.002
2
Chia‐Chi Wang. Contrast‐enhanced ultrasound for hepatocellular carcinoma: Focusing on unique benefits and indicationsAdvances in Digestive Medicine 2019; 6(1): 3 doi: 10.1002/aid2.13111
3
Masatoshi Kudo. Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional TherapyLiver Cancer 2023; 12(4): 289 doi: 10.1159/000532023
4
Amy K. Kim, Michael L. Schilsky. Radiology in TransplantCurrent Transplantation Reports 2014; 1(4): 238 doi: 10.1007/s40472-014-0034-5
5
Christoph F. Dietrich, Christian Pállson Nolsøe, Richard G. Barr, Annalisa Berzigotti, Peter N Burns, Vito Cantisani, Maria Cristina Chammas, Nitin Chaubal, Byung Ihn Choi, Dirk-André Clevert, Xinwu Cui, Yi Dong, Mirko D’Onofrio, J. Brian Fowlkes, Odd Helge Gilja, Pintong Huang, Andre Ignee, Christian Jenssen, Yuko Kono, Masatoshi Kudo, Nathalie Lassau, Won Jae Lee, Jae Young Lee, Ping Liang, Adrian Lim, Andrej Lyshchik, Maria Franca Meloni, Jean Michel Correas, Yasunori Minami, Fuminori Moriyasu, Carlos Nicolau, Fabio Piscaglia, Adrian Saftoiu, Paul S. Sidhu, Ioan Sporea, Guido Torzilli, Xiaoyan Xie, Rongqin Zheng. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2020 – WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUSUltraschall in der Medizin - European Journal of Ultrasound 2020; 41(05): 562 doi: 10.1055/a-1177-0530
6
Pankaj Gupta, Naveen Kalra, Sreedhara B. Chaluvashetty, Shivanand Gamangatti, Amar Mukund, Razik Abdul, VS Shyam, Sanjay Saran Baijal, Chander Mohan. Indian College of Radiology and Imaging Guidelines on Interventions in Hepatocellular CarcinomaIndian Journal of Radiology and Imaging 2022; 32(04): 540 doi: 10.1055/s-0042-1754361
7
Xiaohong Xu, Liangping Luo, Jiexin Chen, Jiexin Wang, Honglian Zhou, Mingyi Li, Zhanqiang Jin, Nianping Chen, Huilai Miao, Manzhou Lin, Wei Dai, Anil T. Ahuja, Yi-Xiang J. Wang. Acoustic Radiation Force Impulse Elastography for Efficacy Evaluation after Hepatocellular Carcinoma Radiofrequency Ablation: A Comparative Study with Contrast-Enhanced UltrasoundBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/901642
8
Davide Roccarina, Matteo Garcovich, Maria Elena Ainora, Laura Riccardi, Maurizio Pompili, Antonio Gasbarrini, Maria Assunta Zocco. Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatmentWorld Journal of Hepatology 2015; 7(14): 1866-1874 doi: 10.4254/wjh.v7.i14.1866
9
Yang Hai, Esika Savsani, Weelic Chong, John Eisenbrey, Andrej Lyshchik. Meta-analysis and systematic review of contrast-enhanced ultrasound in evaluating the treatment response after locoregional therapy of hepatocellular carcinomaAbdominal Radiology 2021; 46(11): 5162 doi: 10.1007/s00261-021-03248-9
10
Lucia Cerrito, Maria Elena Ainora, Giuseppe Cuccia, Linda Galasso, Irene Mignini, Giorgio Esposto, Matteo Garcovich, Laura Riccardi, Antonio Gasbarrini, Maria Assunta Zocco. Dynamic Contrast-Enhanced Ultrasound in the Prediction of Advanced Hepatocellular Carcinoma Response to Systemic and Locoregional TherapiesCancers 2024; 16(3): 551 doi: 10.3390/cancers16030551
11
Jin-Yu Wu, Xiu-Mei Bai, Hong Wang, Qian Xu, Song Wang, Wei Wu, Kun Yan, Wei Yang. The Perfusion Features of Recurrent Hepatocellular Carcinoma After Radiofrequency Ablation Using Contrast-Enhanced Ultrasound and Pathological Stemness Evaluation: Compared to Initial TumorsFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01464
12
Mostafa Atri, Abdulmohsen Alrashed, Ahmad Hassan, Korosh Khalili, Tae Kyoung Kim, Huynh Jung Jang. Negative Predictive Value of Contrast-Enhanced Ultrasound of Liver and Kidney Thermal Ablation Sites for Local Tumour Progression during Long-term Follow-up: A Retrospective Consecutive StudyCanadian Association of Radiologists Journal 2019; 70(4): 434 doi: 10.1016/j.carj.2019.06.011
13
Li Chen, Zhi-xing Liu, Qiu-chen Bi, Jun Zhao, Qing-rong Liang, Qun Tang. Ultrasound-Guided Percutaneous Ethanol-Paclitaxel Combined Therapy for Rabbit VX2 Liver TumorsJournal of Hepatocellular Carcinoma 2021; : 263 doi: 10.2147/JHC.S301083
14
Christoph F. Dietrich, Christian Pállson Nolsøe, Richard G. Barr, Annalisa Berzigotti, Peter N. Burns, Vito Cantisani, Maria Cristina Chammas, Nitin Chaubal, Byung Ihn Choi, Dirk-André Clevert, Xinwu Cui, Yi Dong, Mirko D'Onofrio, J. Brian Fowlkes, Odd Helge Gilja, Pintong Huang, Andre Ignee, Christian Jenssen, Yuko Kono, Masatoshi Kudo, Nathalie Lassau, Won Jae Lee, Jae Young Lee, Ping Liang, Adrian Lim, Andrej Lyshchik, Maria Franca Meloni, Jean Michel Correas, Yasunori Minami, Fuminori Moriyasu, Carlos Nicolau, Fabio Piscaglia, Adrian Saftoiu, Paul S. Sidhu, Ioan Sporea, Guido Torzilli, Xiaoyan Xie, Rongqin Zheng. Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver–Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUSUltrasound in Medicine & Biology 2020; 46(10): 2579 doi: 10.1016/j.ultrasmedbio.2020.04.030
15
Si-Min Ruan, Mei-Qing Cheng, Hui Huang, Hang-Tong Hu, Wei Li, Xiao-Yan Xie, Ming-De Lu, Ming Kuang, Man-Xia Lin, Wei Wang. Application of the CT/MRI LI-RADS Treatment Response Algorithm to Contrast-Enhanced Ultrasound: A Feasibility StudyJournal of Hepatocellular Carcinoma 2022; : 437 doi: 10.2147/JHC.S353914
16
Vincenza Granata, Roberta Fusco, Simona Salati, Antonella Petrillo, Elio Di Bernardo, Roberta Grassi, Raffaele Palaia, Ginevra Danti, Michelearcangelo La Porta, Matteo Cadossi, Gorana Gašljević, Gregor Sersa, Francesco Izzo. A Systematic Review about Imaging and Histopathological Findings for Detecting and Evaluating Electroporation Based Treatments ResponseInternational Journal of Environmental Research and Public Health 2021; 18(11): 5592 doi: 10.3390/ijerph18115592
17
Xiaoer Zhang, Guangliang Huang, Jieyi Ye, Ming Xu, Longfei Cong, Xujin He, Tongyi Huang, Ming Kuang, Xiaoyan Xie. 3-D Contrast-Enhanced Ultrasound Fusion Imaging: A New Technique to Evaluate the Ablative Margin of Radiofrequency Ablation for Hepatocellular CarcinomaUltrasound in Medicine & Biology 2019; 45(8): 1933 doi: 10.1016/j.ultrasmedbio.2019.03.019
18
Zhen Liu, Xiaofei Wang, Lei Xing, Yan Pan, Shengchuan Huang. The Application Comparison of Contrast-Enhanced Ultrasound and Contrast-Enhanced Computed Tomography in Radiofrequency Ablation Treatment for Hepatocellular CarcinomaCancer Biotherapy and Radiopharmaceuticals 2019; 34(10): 621 doi: 10.1089/cbr.2019.2845
19
Orlando Catalano, Francesco Izzo, Paolo Vallone, Fabio Sandomenico, Vittorio Albino, Antonio Nunziata, Roberta Fusco, Antonella Petrillo. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experienceActa Radiologica 2015; 56(2): 133 doi: 10.1177/0284185114521108
20
Pankaj Gupta, Naveen Kalra, Ajay Gulati, Vishnu Dev, Ujjwal Gorsi, Sreedhara B. Cheluvashetty, Praveen Kumar-M, Ajay Duseja, Virendra Singh, Radha K. Dhiman, Manavjit Singh Sandhu. Response Assessment Following Image-Guided Therapy of Hepatocellular CarcinomaJournal of Clinical Interventional Radiology ISVIR 2020; 4(02): 088 doi: 10.1055/s-0040-1708579
21
Richard G. Barr, Pintong Huang, Yan Luo, Xiaoyan Xie, Rongqin Zheng, Kun Yan, Xiang Jing, Yukun Luo, Huixiong Xu, Xiang Fei, Jeong Min Lee. Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and SonazoidAbdominal Radiology 2020; 45(11): 3779 doi: 10.1007/s00261-020-02573-9
22
Weixiang Shi, Ying He, Wenbin Ding, Shenchu Gong, Yilang Wang, Jing Xiao, Bosheng He. Contrast-enhanced ultrasonography used for post-treatment responses evaluation of radiofrequency ablations for hepatocellular carcinoma: a meta-analysisThe British Journal of Radiology 2016; 89(1064): 20150973 doi: 10.1259/bjr.20150973
23
Jeanne M. Horowitz, Ihab R. Kamel, Hina Arif-Tiwari, Sumeet K. Asrani, Nicole M. Hindman, Harmeet Kaur, Michelle M. McNamara, Richard B. Noto, Aliya Qayyum, Tasneem Lalani. ACR Appropriateness Criteria ® Chronic Liver DiseaseJournal of the American College of Radiology 2017; 14(11): S391 doi: 10.1016/j.jacr.2017.08.045
24
Mariella Faccia, Matteo Garcovich, Maria Elena Ainora, Laura Riccardi, Maurizio Pompili, Antonio Gasbarrini, Maria Assunta Zocco. Contrast-Enhanced Ultrasound for Monitoring Treatment Response in Different Stages of Hepatocellular CarcinomaCancers 2022; 14(3): 481 doi: 10.3390/cancers14030481
25
Jeanne M. Horowitz, Ihab R. Kamel, Hina Arif-Tiwari, Sumeet K. Asrani, Nicole M. Hindman, Harmeet Kaur, Michelle M. McNamara, Richard B. Noto, Aliya Qayyum, Tasneem Lalani. ACR Appropriateness Criteria ® Chronic Liver DiseaseJournal of the American College of Radiology 2017; 14(5): S103 doi: 10.1016/j.jacr.2017.02.011
26
Shu-Guang Zheng, Hui-Xiong Xu, Lin-Na Liu. Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasoundWorld Journal of Radiology 2014; 6(1): 7-14 doi: 10.4329/wjr.v6.i1.7
27
Masatoshi Kudo, Tomoko Aoki, Kazuomi Ueshima, Kaoru Tsuchiya, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Satoru Hagiwara, Yasunori Minami, Hiroshi Ida, Naoshi Nishida, Chikara Ogawa, Tetsu Tomonari, Noriaki Nakamura, Hidekatsu Kuroda, Atsushi Takebe, Yoshifumi Takeyama, Masaaki Hidaka, Susumu Eguchi, Stephen L Chan, Masayuki Kurosaki, Namiki Izumi. Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept StudyLiver Cancer 2023; 12(4): 321 doi: 10.1159/000529574